Drugs available to GPs and patients in JerseyDrugs available to GPs and patients in Jersey
Produced by the Freedom of Information officeAuthored by Health and Care Jersey and published on
23 February 2026.Prepared internally, no external costs.
Request 780856922
A
I note that in the response to freedom of information request 728920961 published on 27 August 2025 it was planned for faecal calprotectin testing to be available to General Practitioners in Jersey. Please may you confirm whether this has now been made available.
B
Are the new small molecule drugs ozanimod and estrasimod, and the new biologic mirikizumab available to patients in Jersey with inflammatory bowel disease?
Response
A
The test is not currently available to General Practitioners, though progress has been made towards this; Health and Care Jersey (HCJ) has approval to roll out faecal calprotectin testing to Primary Care, the laboratory has been asked to set up the system option to enable electronic requesting, and – once this is in place – a meeting will be arranged between representatives for HCJ and the Primary Care Board to agree final details and proceed with the rollout.
Currently, and until such time as the test is available through GPs, when patients are referred to HCJ with symptoms suggestive of inflammatory bowel disease (IBD), a faecal calprotectin test will be requested and, if positive, an urgent colonoscopy is arranged (as noted in the Freedom of Information response of August 2025 referenced above).
The full Freedom of Information request and response can be accessed at the link below:
https://www.gov.je/government/freedomofinformation/pages/foi.aspx?ReportID=8833
B
Mirikizumab is available as a hospital-only prescription through Health and Care Jersey.
Ozanimod and estrasimod are not available for prescription through Health and Care Jersey at this time.
gov.je